European drug maker Novartis will license Google’s “smart...
European drug maker Novartis will license Google’s “smart lens” technology for “all ocular medical uses,” Novartis said in a Tuesday news release (http://bit.ly/1ylO6AR). “Google’s key advances in the miniaturization of electronics complement Novartis’s deep pharmaceuticals and medical device expertise,” Novartis…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
said. “Novartis aims to enhance the ways in which diseases are mapped within the body and ultimately prevented.” The company said it will focus on two areas: diabetic patients and those with presbyopia, the diminishing ability to focus on near objects.